- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
UPDATED Apr 24, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,640 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
NEWBRY | kr3.39 | -3.1% | -39.0% | kr82.2m | kr8.00 | PS3.6x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
HHR | AU$0.007 | -12.5% | -79.4% | AU$19.7m | n/a | PE6.7x | E86.3% | n/a | Energy | ||
A108860 | ₩16,630.00 | 2.6% | -16.6% | ₩447.6b | n/a | PS8.4x | E98.9% | n/a | Software | ||
ELF | US$176.98 | 6.4% | 88.6% | US$9.8b | US$206.21 | PE75.9x | E27.2% | n/a | Household | ||
AXSM | US$71.17 | 2.1% | 1.5% | US$3.5b | US$121.13 | PS12.5x | E60.7% | n/a | Pharmaceuticals & Biotech | ||
PRL | CA$22.81 | 7.0% | 248.2% | CA$802.2m | CA$24.37 | PE20.6x | E33.6% | 2.1% | Diversified Financials | ||
ASND | US$143.18 | 0.7% | 87.3% | US$8.3b | US$177.45 | PS28.7x | E63.5% | n/a | Pharmaceuticals & Biotech | ||
WAYS | kr22.35 | -4.9% | -58.3% | kr180.4m | kr39.75 | PS1.6x | E81.8% | 0% | Tech | ||
NVG | zł2.14 | -11.6% | 39.4% | zł74.9m | zł3.71 | PE7.7x | E28.5% | n/a | Diversified Financials | ||
FDE | €34.40 | 7.5% | 1.2% | €179.9m | €64.07 | PE22.9x | E32.3% | n/a | Energy | ||
AGP | €7.66 | 0.3% | 105.9% | €132.6m | €12.75 | PE27x | E22.8% | n/a | Capital Goods | ||
CALTX | kr100.40 | -0.5% | -18.7% | kr5.4b | kr208.00 | PS4.5x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$4.56 | -1.7% | -12.0% | US$191.7m | US$19.00 | PS6.9x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
GWIND | ₺26.50 | 3.8% | 67.8% | ₺14.3b | ₺39.79 | PE22.9x | E60.9% | 1.7% | Utilities | ||
ALKT | US$24.49 | 2.7% | 107.7% | US$2.4b | US$28.70 | PS9x | E80.1% | n/a | Software | ||
RDUE | €9.50 | 0% | 3.9% | €59.4m | €10.50 | PE17.5x | E37.7% | n/a | Capital Goods | ||
AVLL3 | R$3.50 | -7.7% | 26.4% | R$683.7m | R$9.90 | PS1.4x | E101.9% | n/a | Consumer Durables | ||
ESTA | US$48.95 | -6.1% | -30.9% | US$1.4b | US$59.29 | PS8.1x | E65.4% | n/a | Healthcare | ||
OSE | €5.64 | 15.7% | 34.3% | €121.6m | €7.15 | PS54.6x | E92.9% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | kr1.58 | 1.8% | 23.6% | kr429.5m | kr1.80 | PS6x | E96.2% | n/a | Tech | ||
NVDA | US$796.77 | -5.2% | 195.6% | US$2.0t | US$995.62 | PE65.9x | E22.9% | 0.02% | Semiconductors | ||
4480 | JP¥3,710.00 | -2.5% | 6.2% | JP¥123.6b | JP¥5,865.00 | PE46.8x | E23.6% | n/a | Healthcare | ||
PNV | AU$2.09 | 1.5% | 25.5% | AU$1.4b | AU$2.11 | PE904.7x | E49.3% | n/a | Healthcare | ||
CAI | AU$0.13 | 4.0% | -38.1% | AU$98.9m | n/a | PB0.7x | E110.6% | n/a | Materials |